The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions

The addition of cetuximab to platinum-based chemotherapy (cisplatin or carboplatin plus 5-fluorouracil [5-FU]), followed by maintenance cetuximab until disease progression (EXTREME), resulted in the first regimen to yield significantly improved survival outcomes in the first-line treatment of patien...

Full description

Bibliographic Details
Main Authors: Joël Guigay, Makoto Tahara, Lisa Licitra, Ulrich Keilholz, Signe Friesland, Pauline Witzler, Ricard Mesía
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Oncology
Subjects:
cetuximab
docetaxel
paclitaxel
EXTREME
TPEx
B490
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00668/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00668/full

Similar Items